{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:27:28Z","timestamp":1793766448838,"version":"4.6.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006407","name":"Henan Province Natural Science Foundation","doi-asserted-by":"publisher","award":["232300420052"],"award-info":[{"award-number":["232300420052"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.clgc.2026.102633","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:51:59Z","timestamp":1785394319000},"page":"102633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Value of Double-expressor Phenotype and an Exploratory DEP-IPI Risk Model in Primary Testicular Diffuse Large B-cell Lymphoma: A Multicenter Retrospective Cohort Study"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9281-8227","authenticated-orcid":false,"given":"Songqiang","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqing","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2026.102633_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2025.102927","article-title":"Primary testicular lymphoma","volume":"136","author":"Grainger","year":"2025","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.clgc.2026.102633_bib0002","first-page":"1372","article-title":"Clinical characteristics and prognosis of patients with primary testicular diffuse large B-cell lymphoma","volume":"31","author":"Zhang","year":"2023","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.clgc.2026.102633_bib0003","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2147\/CMAR.S407837","article-title":"Real-world data analysis of survival outcomes and central nervous system relapses in testicular diffuse large B cell lymphoma","volume":"15","author":"Lee","year":"2023","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.clgc.2026.102633_bib0004","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/(SICI)1097-0142(20000101)88:1<154::AID-CNCR21>3.0.CO;2-T","article-title":"Testicular lymphoma is associated with a high incidence of extranodal recurrence","volume":"88","author":"Fonseca","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2026.102633_bib0005","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1186\/s12967-024-05140-8","article-title":"Genomic landscape and distinct molecular subtypes of primary testicular lymphoma","volume":"22","author":"Zhang","year":"2024","journal-title":"J Transl Med"},{"key":"10.1016\/j.clgc.2026.102633_bib0006","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1200\/JCO.2011.41.4342","article-title":"Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"30","author":"Green","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2026.102633_bib0007","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1182\/blood-2012-10-460063","article-title":"MYC\/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program","volume":"121","author":"Hu","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.clgc.2026.102633_bib0008","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/ejh.14325","article-title":"Biological findings and clinical outcomes in patients treated with R-CHOP plus high-dose methotrexate as first-line therapy in large B-cell lymphoma with Testis involvement","volume":"114","author":"Li\u00e9vin","year":"2025","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clgc.2026.102633_bib0009","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2141.2012.09247.x","article-title":"Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature","volume":"159","author":"Guirguis","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clgc.2026.102633_bib0010","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1182\/bloodadvances.2020003947","article-title":"Efficacy and safety of prophylactic high-dose MTX in high-risk DLBCL: a treatment intent-based analysis","volume":"5","author":"Jeong","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.clgc.2026.102633_bib0011","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.critrevonc.2007.08.005","article-title":"Primary testicular lymphoma","volume":"65","author":"Vitolo","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.clgc.2026.102633_bib0012","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1200\/JCO.2003.11.141","article-title":"Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group","volume":"21","author":"Zucca","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2026.102633_bib0013","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1038\/leu.2008.230","article-title":"Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)","volume":"22","author":"Klapper","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.clgc.2026.102633_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13164049","article-title":"Testicular diffuse large B-cell lymphoma-clinical, molecular, and immunological features","volume":"13","author":"Pollari","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clgc.2026.102633_bib0015","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/bjh.14392","article-title":"Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era","volume":"176","author":"Kridel","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clgc.2026.102633_bib0016","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1200\/JCO.2010.31.4187","article-title":"First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial","volume":"29","author":"Vitolo","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2026.102633_bib0017","doi-asserted-by":"crossref","first-page":"641.e1","DOI":"10.1016\/j.urolonc.2020.02.027","article-title":"Combined chemotherapy and radiotherapy improves survival in 1897 testicular lymphoma patients from a contemporary cohort","volume":"38","author":"Caumont","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2026.102633_bib0018","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/CU9.0000000000000137","article-title":"Primary testicular lymphoma: clinical characteristics and oncological outcomes","volume":"17","author":"Medina","year":"2023","journal-title":"Curr Urol"},{"key":"10.1016\/j.clgc.2026.102633_bib0019","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11864-018-0555-8","article-title":"Extranodal diffuse large B cell lymphoma: molecular features, prognosis, and risk of Central nervous system recurrence","volume":"19","author":"Ollila","year":"2018","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.clgc.2026.102633_bib0020","first-page":"675","article-title":"Outcome of patients with diffuse large B-cell lymphoma and testicular involvement: real world data","volume":"104","author":"Mocikova","year":"2025","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clgc.2026.102633_bib0021","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12885-020-6711-0","article-title":"Adult primary testicular lymphoma: clinical features and survival in a series of patients treated at a high-volume institution in China","volume":"20","author":"Chen","year":"2020","journal-title":"BMC Cancer"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326001333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326001333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:16:37Z","timestamp":1793765797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767326001333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1558767326001333"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102633","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Value of Double-expressor Phenotype and an Exploratory DEP-IPI Risk Model in Primary Testicular Diffuse Large B-cell Lymphoma: A Multicenter Retrospective Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102633"}}